MedTrace Logo

Itch Relieving Effect of Botox: a Study in Healthy Subjects

NCT02639052 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2017-04-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if Botox is effective in the treatment of an experimentally induced itch that mimics chronic itch in healthy volunteers.

Conditions

Interventions

DRUG

Botox

10 units of Botox will be intradermally injected into one 4x4cm area on the volar forearm on 1st study visit.

DRUG

Saline

10 units of the Saline vehicle will be intradermally injected into one 4x4cm area on the contralateral volar forearm on the 1st study visit.

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Temple University

    lead OTHER

Principal Investigators

  • Gil Yosipovitch, MD · Temple University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-07-31
Completion
2017-01-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02639052 on ClinicalTrials.gov